Sign Up Now
Get instant access to over 1 million+ study documents
OR
Already registered? click here to login
By creating your account, you agree to our terms of service, privacy policy and student honor code.
A controversial drug geared towards enhancing female sexual desire was approved by the United States Food and Drug Administration after being rejected twice. The drug, which is known as flibranserin, was produced by Sprout Pharmaceuticals and is geared towards treatment of low sexual desire in women. The company manufactured the drug on the premise that low sexual desire in women has seemingly been ignored while there are 24 drugs for men for either erectile dysfunction or testosterone replacement (Thacker, 2014). However, the drug has remained controversial and attracted divergent opinions, especially with regards to its potential risks and benefits. As a result, providing recommendation to potential patients inquiring about the drug requires a critical evaluation of these arguments as well as potential risks and benefits based on scientific evidence.
Main Points from Both Sides of the Argument
One of the major arguments that has been used to support the drug is the fact that low sexual desire in women has been ignored by the medical field while men have a variety of drugs for treatment of erectile dysfunction or testosterone replacement. Currently, there are no drugs for common sexual dysfunction forms in women, which makes flibranserin a necessity. Secondly, proponents support the...
They argue that the drug has the potential to jolt neurotransmitters to revive the flagging flames of sexual desire in a woman (Schulte, 2015).
However, those opposed to the drug argue that hypoactive sexual desire disorder (HSDD) is a creation of the drug industry. They state that low sexual desire is basically mismatched sex drives whose solution is not a drug. Secondly, they contend that the creation of this drug is an attempt to medicalize the female body (Thacker, 2014). Third, flibranserin has been opposed on the premise that its creation is for commercial purposes rather than any medical benefits. For instance, the manufacturer of flibranserin, Sprout Pharmaceuticals, recently announced that it’s being sold to Valeant for $1 billion (Watching the Hawks RT, 2015). Therefore, this drug is seen as an attempt by the manufacturer to increase its profits through aggressive marketing.
Potential Benefits and Risks
The potential benefit of flibranserin is bumping neurotransmitters to revive the flagging flames of sexual desires in a woman (Schulte, 2015). Unlike Viagra that enhances blood flow to the genitals, this…
References
Thacker, P.D. (2014, April). How to Handle FDA Rejection. Retrieved August 2, 2017, from http://www.slate.com/articles/double_x/doublex/2014/04/female_viagra_and_the_fda_the_agency_s_rejection_of_flibanserin_has_nothing.html
Schulte, B. (2015, October 15). The First ‘Female Viagra’ is Here. Who Wants It? The Washington Post. Retrieved August 2, 2017, from https://www.washingtonpost.com/lifestyle/magazine/female-viagra-is-here-who-wants-it/2015/10/14/5ff6cb0a-50dd-11e5-933e-7d06c647a395_story.html?utm_term=.f8ff3c0b355d
[Watching the Hawks RT]. (2015, August 20). The Misinformation Behind Female Viagra with Dr. Leonore Tiefer [Video file]. Retrieved from https://www.youtube.com/watch?v=JFG2lEnpmBE&feature=youtu.be
Smith's article raises a very interesting and alarming point, that mental health nurses who consistently deal with anti-psychotic drugs are not trained to educate and help patients suffering from sexual dysfunction. Even worse, they consistently avoid this topic because of embarrassment. Mental health nurses are one of the most highly trained nursing professions, and yet they are influenced by social stigma to not discuss one of the most common patient
4.3. The social environment and the way that sexuality is perceived or constructed by the society is also an important aspect. 4.3. There are still many areas that are not well documented or understood - especially the issue of sexual dysfunction in the elderly. 4.4. There are still questions about the definition of the term sexual dysfunction and many commentators claim that there is a male bias in the presently accepted definition
Sexual addiction is a disorder that is characterized by repetitive and compulsive thoughts about sex and sexual acts. Like other types of addictions the behavior must have a negative impact on the person so that it leads to issues with the person's social, occupational or legal functioning. The current paper describes sexual addictions, the controversy surrounding their diagnosis, and some proposed diagnostic criteria. The second half of the paper discusses
When done on a basis of mutual harmony and choice, sex can be a highly satisfying and emotional activity that brings partners in closer connection to each other. Unfortunately this is not always the case. Sexual Dysfunction Being connected to human interaction, emotion, freedom of choice, and individual body function, an unfortunate possibility is sexual dysfunction. This manifests itself in particular ways in men and women. Generally, problems can be treated
Sexual Disorders According to Croucher (2003), there are five layers in the erotic life of human beings. The first of these is sexual identity. This is the physical differentiation between male and female, which is fixed by the end of the first trimester in the development of the foetus. Transsexuals feel that they have the "wrong sex" and therefore the wrong core identity. The second layer is sexual orientation, which refers
Sexual Issues Affecting a Couple Sexual dysfunctions as well as sexual recital matters are comparatively frequent tribulations in the common population. Sexual dysfunction can be brought about by numerous factors which might upshot from emotional as well as physical grounds. As per the view of Michetti, PM; Rossi, R; Bonanno, D; Tiesi, A and Simonelli, C, (2005), Sexual dysfunction may possibly crop up from emotional factors such as interpersonal or psychosomatic